These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
400 related articles for article (PubMed ID: 26387539)
1. ZEB1 and TCF4 reciprocally modulate their transcriptional activities to regulate Wnt target gene expression. Sánchez-Tilló E; de Barrios O; Valls E; Darling DS; Castells A; Postigo A Oncogene; 2015 Nov; 34(46):5760-70. PubMed ID: 26387539 [TBL] [Abstract][Full Text] [Related]
2. β-catenin/TCF4 complex induces the epithelial-to-mesenchymal transition (EMT)-activator ZEB1 to regulate tumor invasiveness. Sánchez-Tilló E; de Barrios O; Siles L; Cuatrecasas M; Castells A; Postigo A Proc Natl Acad Sci U S A; 2011 Nov; 108(48):19204-9. PubMed ID: 22080605 [TBL] [Abstract][Full Text] [Related]
3. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors. Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963 [TBL] [Abstract][Full Text] [Related]
4. ZEB1 Promotes invasiveness of colorectal carcinoma cells through the opposing regulation of uPA and PAI-1. Sánchez-Tilló E; de Barrios O; Siles L; Amendola PG; Darling DS; Cuatrecasas M; Castells A; Postigo A Clin Cancer Res; 2013 Mar; 19(5):1071-82. PubMed ID: 23340304 [TBL] [Abstract][Full Text] [Related]
5. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression. Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398 [TBL] [Abstract][Full Text] [Related]
6. RHBDD1 promotes colorectal cancer metastasis through the Wnt signaling pathway and its downstream target ZEB1. Zhang M; Miao F; Huang R; Liu W; Zhao Y; Jiao T; Lu Y; Wu F; Wang X; Wang H; Zhao H; Ju H; Miao S; Wang L; Song W J Exp Clin Cancer Res; 2018 Feb; 37(1):22. PubMed ID: 29426364 [TBL] [Abstract][Full Text] [Related]
7. A dynamic exchange of TCF3 and TCF4 transcription factors controls MYC expression in colorectal cancer cells. Shah M; Rennoll SA; Raup-Konsavage WM; Yochum GS Cell Cycle; 2015; 14(3):323-32. PubMed ID: 25659031 [TBL] [Abstract][Full Text] [Related]
8. Oncogenic KRAS signalling promotes the Wnt/β-catenin pathway through LRP6 in colorectal cancer. Lemieux E; Cagnol S; Beaudry K; Carrier J; Rivard N Oncogene; 2015 Sep; 34(38):4914-27. PubMed ID: 25500543 [TBL] [Abstract][Full Text] [Related]
9. A novel ent-kaurane diterpenoid executes antitumor function in colorectal cancer cells by inhibiting Wnt/β-catenin signaling. Ye Q; Yao G; Zhang M; Guo G; Hu Y; Jiang J; Cheng L; Shi J; Li H; Zhang Y; Liu H Carcinogenesis; 2015 Mar; 36(3):318-26. PubMed ID: 25600769 [TBL] [Abstract][Full Text] [Related]
10. Activation of the Wnt/β-catenin pathway represses the transcription of the β-amyloid precursor protein cleaving enzyme (BACE1) via binding of T-cell factor-4 to BACE1 promoter. Parr C; Mirzaei N; Christian M; Sastre M FASEB J; 2015 Feb; 29(2):623-35. PubMed ID: 25384422 [TBL] [Abstract][Full Text] [Related]
11. Preclinical evaluation of destruxin B as a novel Wnt signaling target suppressing proliferation and metastasis of colorectal cancer using non-invasive bioluminescence imaging. Yeh CT; Rao YK; Ye M; Wu WS; Chang TC; Wang LS; Wu CH; Wu AT; Tzeng YM Toxicol Appl Pharmacol; 2012 May; 261(1):31-41. PubMed ID: 22465936 [TBL] [Abstract][Full Text] [Related]
12. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis. Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932 [TBL] [Abstract][Full Text] [Related]
13. Henryin, an ent-kaurane diterpenoid, inhibits Wnt signaling through interference with β-catenin/TCF4 interaction in colorectal cancer cells. Li X; Pu J; Jiang S; Su J; Kong L; Mao B; Sun H; Li Y PLoS One; 2013; 8(7):e68525. PubMed ID: 23844215 [TBL] [Abstract][Full Text] [Related]
14. Attenuation of the beta-catenin/TCF4 complex in colorectal cancer cells induces several growth-suppressive microRNAs that target cancer promoting genes. Schepeler T; Holm A; Halvey P; Nordentoft I; Lamy P; Riising EM; Christensen LL; Thorsen K; Liebler DC; Helin K; Ørntoft TF; Andersen CL Oncogene; 2012 May; 31(22):2750-60. PubMed ID: 21963845 [TBL] [Abstract][Full Text] [Related]
15. The leukemia-associated Mllt10/Af10-Dot1l are Tcf4/β-catenin coactivators essential for intestinal homeostasis. Mahmoudi T; Boj SF; Hatzis P; Li VS; Taouatas N; Vries RG; Teunissen H; Begthel H; Korving J; Mohammed S; Heck AJ; Clevers H PLoS Biol; 2010 Nov; 8(11):e1000539. PubMed ID: 21103407 [TBL] [Abstract][Full Text] [Related]
16. The lncRNA CRNDE promotes colorectal cancer cell proliferation and chemoresistance via miR-181a-5p-mediated regulation of Wnt/β-catenin signaling. Han P; Li JW; Zhang BM; Lv JC; Li YM; Gu XY; Yu ZW; Jia YH; Bai XF; Li L; Liu YL; Cui BB Mol Cancer; 2017 Jan; 16(1):9. PubMed ID: 28086904 [TBL] [Abstract][Full Text] [Related]
17. CREPT/RPRD1B, a recently identified novel protein highly expressed in tumors, enhances the β-catenin·TCF4 transcriptional activity in response to Wnt signaling. Zhang Y; Liu C; Duan X; Ren F; Li S; Jin Z; Wang Y; Feng Y; Liu Z; Chang Z J Biol Chem; 2014 Aug; 289(33):22589-22599. PubMed ID: 24982424 [TBL] [Abstract][Full Text] [Related]
18. ZEB1 represses E-cadherin and induces an EMT by recruiting the SWI/SNF chromatin-remodeling protein BRG1. Sánchez-Tilló E; Lázaro A; Torrent R; Cuatrecasas M; Vaquero EC; Castells A; Engel P; Postigo A Oncogene; 2010 Jun; 29(24):3490-500. PubMed ID: 20418909 [TBL] [Abstract][Full Text] [Related]
20. Context-dependent activation of Wnt signaling by tumor suppressor RUNX3 in gastric cancer cells. Ju X; Ishikawa TO; Naka K; Ito K; Ito Y; Oshima M Cancer Sci; 2014 Apr; 105(4):418-24. PubMed ID: 24447505 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]